Postoperative surveillance for renal cell carcinoma: A multifactorial histological subtype specific protocol

BJU International

Volumn 104, Issue 6, 2009, Pages 778-785

  Siddiqui, Sameer A ^a   Frank, Igor ^a   Cheville, John C ^b   Lohse, Christine M ^b   Leibovich, Bradley C ^a   Blute, Michael L ^a  

^a HENRY FORD HOSPITAL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Nephrectomy; Recurrence; Renal cell carcinoma; Surveillance

Indexed keywords

ABDOMINAL CANCER; ALGORITHM; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; CLEAR CELL CARCINOMA; COST BENEFIT ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEPHRECTOMY; OUTCOME ASSESSMENT; PAPILLARY CARCINOMA; PARTIAL NEPHRECTOMY; POSTOPERATIVE PERIOD; PREDICTIVE VALIDITY; PRIORITY JOURNAL; RECURRENCE RISK; THORAX TUMOR; TREATMENT OUTCOME;

ABDOMINAL NEOPLASMS; CARCINOMA, RENAL CELL; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEPHRECTOMY; PROGNOSIS;

EID: 69249097051     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08499.x     Document Type: Article

References (29)

1. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2008. CA Cancer J Clin 2008 58 : 71 96
2. Frank I, Blute ML, Cheville JC et al. A multifactorial postoperative surveillance model for patients with surgically treated clear cell renal cell carcinoma. J Urol 2003 170 : 2225 2232
3. Campbell SC, Novick AC, Bukowski RM. Renal tumors. In Walsh PC, Retik AB, Vaughan ED, Wein AJ, Campbell-Walsh Urology. Philadelphia : WB Saunders, 2007 : 2762 2772
4. Itano NB, Blute ML, Spotts B, Zincke H. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy. J Urol 2000 164 : 322 325
5. Piltz S, Meimarakis G, Wichmann MW, Hatz R, Schildberg FW, Fuerst H. Long-term results after pulmonary resection of renal cell carcinoma metastases. Ann Thorac Surg 2002 73 : 1082 1087
6. Alves A, Adam R, Majno P et al. Hepatic resection for metastatic renal tumors: is it worthwhile? Ann Surg Oncol 2003 10 : 705 710
7. Coppage L, Shaw C, Curtis AM. Metastatic disease to the chest in patients with extrathoracic malignancy. J Thorac Imaging 1987 2 : 24 37
8. Levy DA, Slaton JW, Swanson DA, Dinney CP. Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma. J Urol 1998 159 : 1163 1167
9. Hafez KS, Novick AC, Campbell SC. Patterns of tumor recurrence and guidelines for followup after nephron sparing surgery for sporadic renal cell carcinoma. J Urol 1997 157 : 2067 2070
10. Sandock DS, Seftel AD, Resnick MI. A new protocol for the followup of renal cell carcinoma based on pathological stage. J Urol 1995 154 : 28 31
11. Gofrit ON, Shapiro A, Kovalski N, Landau EH, Shenfeld OZ, Pode D. Renal cell carcinoma: evaluation of the 1997 TNM system and recommendations for follow-up after surgery. Eur Urol 2001 39 : 669 674
12. Motzer RJ, Boston B, Carducci MA et al. The NCCN Kidney Cancer Practice Guidelines in Oncology National Comprehensive Cancer Network Inc, 1st edn. 2006
13. Ljungberg B, Alamdari FI, Rasmuson T, Roos G. Follow-up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy. BJU Int 1999 84 : 405 411
14. Lam JS, Shvarts O, Leppert JT, Pantuck AJ, Figlin RA, Belldegrun AS. Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system. J Urol 2005 174 : 466 472
15. Kattan MW, Reuter V, Motzer RJ, Katz J, Russo P. A postoperative prognostic nomogram for renal cell carcinoma. J Urol 2001 166 : 63 7
16. Amin MB, Tamboli P, Javidan J et al. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol 2002 26 : 281 291
17. Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 2003 27 : 612 624 (Pubitemid 36514472)
18. Storkel S, Eble JN, Adlakha K et al. Classification of renal cell carcinoma: workgroup, 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 1997 80 : 987 989
19. Lohse CM, Blute ML, Zincke H, Weaver AL, Cheville JC. Comparison of standardized and nonstandardized nuclear grade of renal cell carcinoma to predict outcome among 2,042 patients. Am J Clin Pathol 2002 118 : 877 886
20. Gold MR, Siegel JE, Russell LB, Weinstein MC eds. Cost-Effectiveness in Health and Medicine. New York : Oxford University Press, 1996
21. Kavolius JP, Mastorakos DP, Pavlovich C, Russo P, Burt ME, Brady MS. Resection of metastatic renal cell carcinoma. J Clin Oncol 1998 16 : 2261 6
22. Montie JE. Follow-up after partial or total nephrectomy for renal cell carcinoma. Urol Clin North Am 1994 21 : 589 592
23. Moch H, Gasser T, Amin MB, Torhorst J, Sauter G, Mihatsch MJ. Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors. Cancer 2000 89 : 604 614
24. Tsui KH, Shvarts O, Smith RB, Figlin RA, deKernion JB, Belldegrun A. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria. J Urol 2000 163 : 1090 1095
25. Bretheau D, Lechevallier E, de Fromont M, Sault MC, Rampal M, Coulange C. Prognostic value of nuclear grade of renal cell carcinoma. Cancer 1995 76 : 2543 9
26. Sengupta S, Lohse CM, Leibovich BC et al. Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness. Cancer 2005 104 : 511 520
27. Zisman A, Pantuck AJ, Dorey F et al. Improved prognostication of renal cell carcinoma using an integrated staging system. J Clin Oncol 2001 19 : 1649 57
28. Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKena WG. Clinical Oncology, 3rd edn. Orlando : Churchill Livingstone, 2004
29. Marshall ME, Pearson T, Simpson W, Butler K, McRoberts W. Low incidence of asymptomatic brain metastases in patients with renal cell carcinoma. Urology 1990 36 : 300 302